Articles by Andrea Charles

Is your supply chain prepared for a natural disaster? Natural disasters, such as earthquakes, hurricanes and tsunamis continue to have a devastating effect on communities and businesses. Due to their uncertainty companies are often ill- prepared to deal with the widespread disruption they can cause to the supply chain. Getting pharmaceuticals to the right patient at the right time is a complex...Full Article »

Today  Capgemini Consulting releases the  10 th annual Vision and Reality report which examines how the pharmaceutical industry can better communicate with physicians and the wider medical community. The report surveyed nearly 1,800 specialist physicians across Oncology, Hematology, Cardiology, Rheumatology and Neurology. Pharma IQ spoke with Hala Qanadilo, Principal, and Timothy...Full Article »

In part one of this interview Dan Sfera from The Clinical Trials Guru, speaks to Andrea Charles from Pharma IQ, about the big trends making an impact in clinical research, the FDA's concern over the lack of PI oversight in clinical trials and getting involved in phase one studies. Pharma IQ: What really big trends you are seeing in clinical research? D Sfera:...Full Article »

GCOF took  brave step this year and was un-conferenced. The 3rd Annual Global Clinical Outsourcing Forum, took place in Amsterdam from the 24th-25th April 2012. As a result of feedback from last year’s attendees,  the IQPC  event team changed the format to create an event that provided a completely interactive, discussion based forum. Senior Conference Director Nicola Ambler...Full Article »

“ Continuous manufacturing is done in almost all manufacturing industries, except for wine, hard spirits, and pharmaceuticals. Defining a batch is up to the manufacturer but consistent with QbD, so why don’t they do it? It means change and change only happens when there is absolute need ,” said Cristina Falcão, Pharma IQ Columnist in a recent interview with Pharma IQ....Full Article »

The DIA Global Award winners were announced this morning at the opening plenary session of DIA 2011.  Recognised for a range of achievements the winners were: Distinguished Career Award – Europe Martin Terberger Retired, European Commission  Founders Service Award - Europe Sabine Brosch, PharmD, PhD Scientific Administrator, Pharmacovigilance and Risk Management...Full Article »

Regulatory guidelines are having a huge impact on new pharmaceutical development. With more emphasis on patient safety than ever before, the number of new drugs being approved has been reduced.  In New Drug Approvals FDA/EMA 2010 , Krishan Maggon, Consultant Pharmaceutical Biotechnology R&D & Advisor, said: “The FDA approved 21 new drugs in 2010 compared to 25 in 2009 and 21...Full Article »

Richard Morphy from the Medicinal Chemistry Dept at the Schering-Plough Research Institute, joins Pharma IQ to discuss tactical and strategic partnerships and etablishing efficient discovery outsourcing strategies. Pharma IQ: Please tell us about your current role. R Morphy:   I’ve been responsible for chemistry outsourcing and partnering activities from Organon and...Full Article »

Chandrashekhar Krishnan, Executive Director of Transparency International (UK), joins Pharma IQ to discuss the Bribery Act, which is currently under review by the UK Government. The government has delayed the implementation of the Act to allow for clearer guidelines. Transparency International, which is a global non-governmental organisation that is committed to combating corruption. Their...Full Article »

Jim Thomson, Chair, European Alliance for Safe Medicines (EAASM), joins Pharma IQ, to discuss the challenge of pharmaceutical counterfeiting. Pharma IQ: Could you outline the importance of the EAASM and any important projects you’ve been involved in? J Thomson: Sure, yes. It would be arrogant of me to say how important the organisation is but I can tell you what we are. We’re a multi...Full Article »

Klaus Menges, Division of Strategy and Planning, at the Federal Institute for Drugs and Medical Devices, BfArM, joins Pharma IQ, to discuss successful strategies for eCTD submission. To listen to the podcast now go to Successful Strategies for eCTD Submission. Pharma IQ: Ensuring eCTD readiness is now critical for all businesses wishing to gain first time market approval – what would...Full Article »